SSTR2 and neoplasm: Correlating methylation levels of 12 CpG methylation sites at the SSTR2 promoter region with tumor grades in 96 NIH patient samples, we found increased methylation levels at higher tumor grades, as shown for one of the CpG methylation sites (cg19129425; P < 0.05) in Fig. 1A.